Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 222

    1.

    Autoregulation of glomerular filtration rate in patients with type 2 diabetes during isradipine therapy.

    Christensen PK, Akram K, Kønig KB, Parving HH.

    Diabetes Care. 2003 Jan;26(1):156-62.PMID: 12502673 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients.

    Christensen PK, Lund S, Parving HH.

    Kidney Int. 2001 Oct;60(4):1435-42.PMID: 11576357 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The impact of glycaemic control on autoregulation of glomerular filtration rate in patients with non-insulin dependent diabetes.

    Christensen PK, Lund S, Parving HH.

    Scand J Clin Lab Invest. 2001 Feb;61(1):43-50.PMID: 11300610 [PubMed - indexed for MEDLINE]Related articles

    4.

    A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.

    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.

    Clin Nephrol. 2001 May;55(5):375-83.PMID: 11393383 [PubMed - indexed for MEDLINE]Related articles

    5.

    Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study.

    Rossing K, Christensen PK, Hansen BV, Carstensen B, Parving HH.

    Diabetes Care. 2003 Jan;26(1):150-5.PMID: 12502672 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients.

    Christensen PK, Hansen HP, Parving HH.

    Kidney Int. 1997 Nov;52(5):1369-74.PMID: 9350661 [PubMed - indexed for MEDLINE]Related articles

    7.

    Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.

    Diabetes. 1997 Mar;46(3):481-7.PMID: 9032106 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.

    Rossing K, Christensen PK, Jensen BR, Parving HH.

    Diabetes Care. 2002 Jan;25(1):95-100.PMID: 11772908 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies.

    Christensen PK, Hommel EE, Clausen P, Feldt-Rasmussen B, Parving HH.

    Kidney Int. 1999 Oct;56(4):1517-23.PMID: 10504503 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.

    Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R.

    Diabetes. 1996 Feb;45(2):216-22.PMID: 8549868 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.

    Maccariello ER, Genelhu de Abreu Fagundes V, Francischetti EA.

    Am J Hypertens. 1997 May;10(5 Pt 1):541-5.PMID: 9160765 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.

    Clin Ther. 2008 Mar;30(3):482-98.PMID: 18405787 [PubMed - indexed for MEDLINE]Related articles

    14.

    Evaluation of antihypertensive effects of once-a-day isradipine and fosinopril: a double-blind crossover study by means of ambulatory blood pressure monitoring.

    Perticone F, Pugliese F, Marcantonio AM, Cloro C, Maio R, Mattioli PL.

    Clin Cardiol. 1995 Jul;18(7):401-7.PMID: 7554545 [PubMed - indexed for MEDLINE]Related articles

    15.

    Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial.

    Schjoedt KJ, Christensen PK, Jorsal A, Boomsma F, Rossing P, Parving HH.

    Nephrol Dial Transplant. 2009 Nov;24(11):3343-9. Epub 2009 Jun 26.PMID: 19561152 [PubMed - in process]Related articles

    16.

    Renal autoregulation is normal in newly diagnosed, normotensive, NIDDM patients.

    New JP, Marshall SM, Bilous RW.

    Diabetologia. 1998 Feb;41(2):206-11.PMID: 9498655 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.

    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C; Melbourne Diabetic Nephropathy Study Group.

    Diabet Med. 2004 Nov;21(11):1192-9.PMID: 15498085 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.

    Jacobsen P, Andersen S, Rossing K, Hansen BV, Parving HH.

    Nephrol Dial Transplant. 2002 Jun;17(6):1019-24.PMID: 12032191 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.

    Diabetes Care. 2000 Dec;23(12):1725-30.PMID: 11128341 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data